Euglycemic control : does it affect the incidence of chest infection in ICU patients ?
Background Acute hyperglycemia in ICU patients is associated with increased risk of nosocomial infections by raised plasma levels of proinfl ammatory cytokines, stimulates muscle protein degradation, and inhibits protein synthesis, which could contribute to muscle wasting. Euglycemic control with in...
Gespeichert in:
Veröffentlicht in: | Ain-Shams Journal of Anaesthesiology 2014, Vol.7 (4), p.504-508 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Acute hyperglycemia in ICU patients is associated with increased risk of nosocomial infections
by raised plasma levels of proinfl ammatory cytokines, stimulates muscle protein degradation,
and inhibits protein synthesis, which could contribute to muscle wasting. Euglycemic control
with insulin reduced septicemia and the need for prolonged antibiotic therapy, prevented
nosocomial infection, accelerated resolution of infl ammation, and reduced muscle catabolism.
Patients and methods
A total of 200 patients of both sex, diabetic or nondiabetic, aging between 20 and 70 years,
admitted to the ICU of Ain Shams University Hospitals for more than 2 days who gave written
and informed consent, were enrolled in the study. Age, sex, clinical assessment for chest
infection, C-reactive protein, chest radiography, random blood sugar, HbA1C, and serum K+
were recorded at the time of ICU admission. Patients were divided into two groups according
to patient approval. Group I includes euglycemic control group (n = 100 patients), in which
blood sugar was kept between 100 and 120 mg/dl using regular insulin infusion; and group II
(n = 100 patients), in which the standard of care was an intravenous insulin infusion titrated
to maintain blood glucose between 120 and 180 mg/dl. Blood sugar was measured every
1 h in both groups; indicator of chest infection (clinical sings, C-reactive protein, and chest
radiography) was carried out daily.
Results
Regarding all demographic data (age and sex), there were no statistically signifi cant differences
between the studied groups (P = 0.744 and 0.730, respectively). With regard to the duration
of ICU stay, there was a statistically signifi cant higher rate of ICU stay for more than 7 days
among patients of group II (P < 0.001). Comparing between the incidence of chest infection in
group I and group II, there was low incidence of chest infection in group I [four patients (4%)],
whereas 18 patients (18%) of group II (22 of 200 patients) showed chest infection (P = 0.003).
Conclusion
We concluded that euglycemic control reduces the incidence of chest infection in ICU patients |
---|---|
ISSN: | 1687-7934 2090-925X |
DOI: | 10.4103/1687-7934.145681 |